Funding is available through an NINDS Translational Research grant to support new drug discovery projects that are based on on-going studies of the applicant and have clear relevance for neurodegenerative disease.

Interested applicants should visit http://www.neurodiscovery.harvard.edu/research/lddn_rfa_2.html to read the announcement and RFA for further information about the program and detailed instructions on how to apply are located.

The following time-table should be kept in mind:

• March 3, 2008 - Letter of intent
• April 1, 2008 - Full application package
• May 2008  - Notification of decisions sent to applicants
• September 2, 2008  - New applicants arrive at NCDDN in Cambridge, MA

All materials and general enquires can be sent to Eiblis Goldings at This email address is being protected from spam bots, you need Javascript enabled to view it